Rezolute: Phase 3 sunRIZE Data For Ersodetug Warrants Downgrade To Sell Rating

Rezolute, Inc. is downgraded to a Sell after its phase 3 sunRIZE trial for congenital hyperinsulinism failed. Learn more ...

Envoy Medical to Host Fireside Chat with CEO Brent Lucas and the First Acclaim(R) Cochlear ...

Detailed price information for Envoy Medical Inc (COCH-Q) from The Globe and Mail including charting and trades.